Despite such initiatives, respondents noted that applications of genomics for stratified medicine delivery remain somewhat limited at present. However, they did mention some important innovations, notably in the field of cancer therapeutics, while national audits show an increase in the provision of novel drugs requiring companion diagnostics. Stratified medicine was seen as helping to address these problems by transforming understanding of the role of genetic variation in disease and enabling more accurate disease classification, diagnosis and targeting of drugs and other interventions.